company background image
N6B logo

Labcorp Holdings DB:N6B Stock Report

Last Price

€226.00

Market Cap

€19.3b

7D

1.8%

1Y

16.5%

Updated

22 Nov, 2024

Data

Company Financials +

Labcorp Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Labcorp Holdings
Historical stock prices
Current Share PriceUS$226.00
52 Week HighUS$231.00
52 Week LowUS$175.50
Beta1.04
11 Month Change12.44%
3 Month Change10.24%
1 Year Change16.49%
33 Year Change-9.64%
5 Year Change43.95%
Change since IPO285.73%

Recent News & Updates

Recent updates

Shareholder Returns

N6BDE HealthcareDE Market
7D1.8%0.1%-0.02%
1Y16.5%17.2%8.2%

Return vs Industry: N6B matched the German Healthcare industry which returned 15.7% over the past year.

Return vs Market: N6B exceeded the German Market which returned 7.4% over the past year.

Price Volatility

Is N6B's price volatile compared to industry and market?
N6B volatility
N6B Average Weekly Movement3.0%
Healthcare Industry Average Movement4.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.4%

Stable Share Price: N6B has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: N6B's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199561,975Adam Schechterwww.labcorp.com

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Labcorp Holdings Inc. Fundamentals Summary

How do Labcorp Holdings's earnings and revenue compare to its market cap?
N6B fundamental statistics
Market cap€19.29b
Earnings (TTM)€418.21m
Revenue (TTM)€12.21b

46.0x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
N6B income statement (TTM)
RevenueUS$12.71b
Cost of RevenueUS$9.16b
Gross ProfitUS$3.55b
Other ExpensesUS$3.11b
EarningsUS$435.50m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.21
Gross Margin27.92%
Net Profit Margin3.43%
Debt/Equity Ratio83.2%

How did N6B perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

56%

Payout Ratio

Does N6B pay a reliable dividends?

See N6B dividend history and benchmarks
When do you need to buy N6B by to receive an upcoming dividend?
Labcorp Holdings dividend dates
Ex Dividend DateNov 26 2024
Dividend Pay DateDec 13 2024
Days until Ex dividend2 days
Days until Dividend pay date19 days

Does N6B pay a reliable dividends?

See N6B dividend history and benchmarks